11-94498091-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The ENST00000544612.6(ANKRD49):āc.279C>Gā(p.Leu93=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.558 in 1,609,474 control chromosomes in the GnomAD database, including 252,940 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.57 ( 25048 hom., cov: 31)
Exomes š: 0.56 ( 227892 hom. )
Consequence
ANKRD49
ENST00000544612.6 synonymous
ENST00000544612.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.25
Genes affected
ANKRD49 (HGNC:25970): (ankyrin repeat domain 49) Involved in positive regulation of transcription, DNA-templated. Predicted to be located in nucleus. Predicted to be active in cytosol. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 11-94498091-C-G is Benign according to our data. Variant chr11-94498091-C-G is described in ClinVar as [Benign]. Clinvar id is 403103.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.25 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.623 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANKRD49 | NM_017704.3 | c.279C>G | p.Leu93= | synonymous_variant | 3/3 | ENST00000544612.6 | NP_060174.2 | |
ANKRD49 | XM_017017941.2 | c.279C>G | p.Leu93= | synonymous_variant | 3/3 | XP_016873430.1 | ||
MRE11 | XM_011542837.3 | c.-105-5185G>C | intron_variant | XP_011541139.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANKRD49 | ENST00000544612.6 | c.279C>G | p.Leu93= | synonymous_variant | 3/3 | 1 | NM_017704.3 | ENSP00000440396 | P1 |
Frequencies
GnomAD3 genomes AF: 0.572 AC: 86744AN: 151774Hom.: 25026 Cov.: 31
GnomAD3 genomes
AF:
AC:
86744
AN:
151774
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.533 AC: 132508AN: 248708Hom.: 35769 AF XY: 0.530 AC XY: 71214AN XY: 134440
GnomAD3 exomes
AF:
AC:
132508
AN:
248708
Hom.:
AF XY:
AC XY:
71214
AN XY:
134440
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.557 AC: 811808AN: 1457582Hom.: 227892 Cov.: 39 AF XY: 0.553 AC XY: 400514AN XY: 724704
GnomAD4 exome
AF:
AC:
811808
AN:
1457582
Hom.:
Cov.:
39
AF XY:
AC XY:
400514
AN XY:
724704
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.572 AC: 86817AN: 151892Hom.: 25048 Cov.: 31 AF XY: 0.565 AC XY: 41962AN XY: 74222
GnomAD4 genome
AF:
AC:
86817
AN:
151892
Hom.:
Cov.:
31
AF XY:
AC XY:
41962
AN XY:
74222
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1739
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at